Evidence map›Paper›PMID 34266468›Full record

ArticleImplementation science : IS2021

Rationale and protocol for a cluster randomized pragmatic clinical trial testing behavioral economic implementation strategies to improve tobacco treatment rates for cancer patients who smoke.

Brian P Jenssen, Robert Schnoll, Rinad Beidas, Justin Bekelman, Anna-Marika Bauer, Callie Scott, Sarah Evers-Casey, Jody Nicoloso, Peter Gabriel, David A Asch and 14 more

2 registry-linked trialsOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Implementation science : IS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04737031 nacompletednot on this map

Improving Tobacco Treatment Rates for Outpatient Cancer Patients Who Smoke

TypeinterventionalSponsorAbramson Cancer Center at Penn MedicineRan2021 to 2022Enrolled2,146ConditionsCancer, Smoking, Tobacco Use, Nicotine DependenceArmsClinician Nudge, Patient Nudge
NCT05787249 nacompletednot on this mapstarted 2023, after this paper: background citation

Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts

TypeinterventionalSponsorAbramson Cancer Center at Penn MedicineRan2023 to 2025Enrolled1,358ConditionsBreast CancerArmsPatient nudge, Provider nudge
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 1 country.

Brian P JenssenDepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. Jenssenb@chop.edu.ORCID 0000-0001-6082-4931
Robert SchnollDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Rinad BeidasPenn Center for Cancer Care Innovation, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Justin BekelmanPenn Center for Cancer Care Innovation, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Anna-Marika BauerDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Callie ScottPenn Center for Cancer Care Innovation, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Sarah Evers-CaseyComprehensive Smoking Treatment Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Jody NicolosoComprehensive Smoking Treatment Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Peter GabrielPenn Center for Cancer Care Innovation, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
David A AschDivision of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Alison ButtenheimCenter for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, USA.
Jessica ChenUniversity of Pennsylvania Health System, Philadelphia, USA.
Julissa MeloUniversity of Pennsylvania Health System, Philadelphia, USA.
Lawrence N ShulmanPenn Center for Cancer Care Innovation, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Alicia B W CliftonPenn Center for Cancer Care Innovation, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Adina LiebermanDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Tasnim SalamPenn Center for Cancer Care Innovation, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Kelly ZentgrafDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Katharine A RendlePenn Center for Cancer Care Innovation, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Krisda ChaiyachatiPenn Center for Cancer Care Innovation, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Rachel SheltonDepartment of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, USA.
E Paul WileytoCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Sue WareDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
Frank LeonePulmonary, Allergy, & Critical Care Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
University of Pennsylvania · USAbramson Cancer CenterHospital of the University of Pennsylvania · USUniversity of Pennsylvania Health System · USColumbia University · USEnvironmental and Occupational Health Sciences Institute · US

Funding

Research ProgramP50CA244690 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHULMAN, LAWRENCE N. · 2020 to 2024
$4.9M
A Patient-Oriented Research Mentoring Program in Tobacco Dependence ResearchK24DA045244 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Robert Adam Schnoll · 2018 to 2026
$1.7M
Telemedicine Utilization and Impacts on Access Among Rural Medicare BeneficiariesK08AG065444 · NIA · UNIVERSITY OF PENNSYLVANIA · PI CHAIYACHATI, KRISDA H · 2021 to 2022
$340k
NCI NIH HHS P50 CA244690NIA NIH HHS K08 AG065444NIDA NIH HHS K24 DA045244
6 · The paper itself

Abstract

backgroundRoutine evidence-based tobacco use treatment minimizes cancer-specific and all-cause mortality, reduces treatment-related toxicity, and improves quality of life among patients receiving cancer care. Few cancer centers employ mechanisms to systematically refer patients to evidence-based tobacco cessation services. Implementation strategies informed by behavioral economics can increase tobacco use treatment engagement within oncology care.

methodsA four-arm cluster-randomized pragmatic trial will be conducted across nine clinical sites within the Implementation Science Center in Cancer Control Implementation Lab to compare the effect of behavioral economic implementation strategies delivered through embedded messages (or "nudges") promoting patient engagement with the Tobacco Use Treatment Service (TUTS). Nudges are electronic medical record (EMR)-based messages delivered to patients, clinicians, or both, designed to counteract known patient and clinician biases that reduce treatment engagement. We used rapid cycle approaches (RCA) informed by relevant stakeholder experiences to refine and optimize our implementation strategies and methods prior to trial initiation. Data will be obtained via the EMR, clinician survey, and semi-structured interviews with a subset of clinicians and patients. The primary measure of implementation is penetration, defined as the TUTS referral rate. Secondary outcome measures of implementation include patient treatment engagement (defined as the number of patients who receive FDA-approved medication or behavioral counseling), quit attempts, and abstinence rates. The semi-structured interviews, guided by the Consolidated Framework for Implementation Research, will assess contextual factors and patient and clinician experiences with the nudges. DISCUSSION: This study will be the first in the oncology setting to compare the effectiveness of nudges to clinicians and patients, both head-to-head and in combination, as implementation strategies to improve TUTS referral and engagement. We expect the study to (1) yield insights into the effectiveness of nudges as an implementation strategy to improve uptake of evidence-based tobacco use treatment within cancer care, and (2) advance our understanding of the multilevel contextual factors that drive response to these strategies. These results will lay the foundation for how patients with cancer who smoke are best engaged in tobacco use treatment and may lead to future research focused on scaling this approach across diverse centers.

trial registrationClinicaltrials.gov, NCT04737031 . Registered 3 February 2021.

Indexed as

NeoplasmsSmokingEconomics, BehavioralHumansPragmatic Clinical Trials as TopicQuality of LifeRandomized Controlled Trials as TopicTobacco UseBehavioral economicsElectronic health recordPragmatic trialsTobacco useTobacco use treatment

Identifiers

PMID34266468
PMCPMC8281481
OpenAlexW3177786488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.